The Horizons Tracker
JULY 13, 2022
The researchers have tracked over 50,000 high-growth businesses across the UK since 2011, with 1,628 of these identified as spinouts. “And it’s also true in terms of the exit successes of these spinout businesses,” the authors explain. “10.4% of the UK’s spinouts have exited (i.e. of the wider high-growth population.”
Women on Business
JULY 5, 2011
My plan was to make a career transition and I had accepted the fact that I’d probably have to take a short term pay cut from my pharmaceutical sales job to transition into marketing with a higher long term salary potential. For most laid off job seekers, however, this new normal is a bitter pill to swallow and a difficult reality to accept.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Michael Lee Stallard
SEPTEMBER 16, 2015
Pfizer, the multinational pharmaceutical giant, has become increasingly intentional about shaping its culture. You can see evidence of Pfizer’s commitment in Ian Read’s letter to stakeholders the year after he became CEO: In 2011, we thoroughly explored what our culture is and how it needs to evolve. Pfizer people care.
Marshall Goldsmith
JUNE 20, 2014
A classic problem of smart, successful people is Adding Too Much Value. It is extremely difficult for successful people to listen to other people tell them something that they already know without communicating somehow that (a) they already knew it and (b) they know a better way. I asked my coaching client J.P.
You're Not the Boss of Me
APRIL 20, 2014
I wrote this post in September, 2011. And, if we expect them to bring all of themselves to work and dedicate their energies to the success of our enterprises, we must also care about them. Ms Ingraham worked as an Administrative Assistant for a pharmaceutical company in New Jersey. There are lessons here worth repeating. .
QAspire
JANUARY 24, 2010
He was a marketing executive with a large pharmaceutical company when he decided to pursue his calling and start a fitness center. What started as a two member team was now a successful fitness center running round the clock with a number of trained instructors and some very good facilities. He neither had space nor money to start out.
Harvard Business Review
AUGUST 17, 2012
Cipla, an India-based producer of low cost antiretroviral drugs (ARVs) is one of the biggest success stories in the pharma industry. What's the reason for Cipla's success and should it worry the likes of Merck and Hoffman La Roche? In the US, Cipla sells its products generic pharmaceutical companies such as Teva and Eagle.
Expert insights. Personalized for you.
107 
Let's personalize your content